Skip to main content
. 2017 Jan 3;3(1):e000363. doi: 10.1136/rmdopen-2016-000363

Figure 1.

Figure 1

MTX-PG concentrations and efficacy. (A) Pharmacokinetics of MTX-PG concentrations with the mean MTX dose; (B) DAS28 and (C) cut-off values at week 12 for ΔDAS28>1.2 at week 24. *p<0.05. AUC, area under the curve; DAS28, Disease Activity Score for 28 joints; MTX-PG, methotrexate polyglutamate.